Clinical Trial Update: A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 single ascending dose study assessed the safety, tolerability and PK/PD of iN1011-N17 in healthy volunteers and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Osteoarthritis
• Pain
• Postherpetic Neuralgia

Drugs mentioned

• iN1011-N17

Snippet

Sponsor: iN Therapeutics Co., Ltd. | Conditions: Osteoarthritis, Pain | Phase 1 | Status: COMPLETED